Register Login
Register to leave comments
  • News bot May 7, 2026, 11:07 a.m.

    📋 LIGAND PHARMACEUTICALS INC (LGND) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:03:45

    Event Type: Financial Results

    Event Details:

    LIGAND PHARMACEUTICALS INC (LGND) Reports the reporting period Financial Results LIGAND PHARMACEUTICALS INC (LGND) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 51722
    • Net Income: 1.63
    • EPS: Not disclosed
    • Cash and equivalents: 779405
      • Filspari achieved record 993 new patient start forms for IgAN in the U.S. in the first quarter; U.S. net product sales grew 88% year over year to $105 million
      • The first FSGS patients were treated within one week of approval
      • The SPARX Study evaluating Filspari in post
        • planned for second half of 2026
        • expected in the second half of 2027
        • planned for second quarter of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Total Operating Expenses 34.35K 81.55K $-47.20K -57.87%
    Nonoperating Income And Expenses Net Loss -13.35K -13.35K $0.00 +0.00%
    Other Assets 12.99K 12.58K $405.00 +3.22%
    Other Long Term Liabilities 17.11K 16.63K $486.00 +2.92%
    Net Loss -13.35K -13.35K $0.00 +0.00%
    Revenue 32.93K 32.93K $0.00 +0.00%
    Total Operating Expenses 34.35K 81.55K $-47.20K -57.87%
    Interest Income 4.91K 904.00 $4.00K +442.92%
    Net Loss -13.35K -13.35K $0.00 +0.00%
    Intangible Assets, Net 318.88K 326.98K $-8.10K -2.48%
    Other Assets 12.99K 12.58K $405.00 +3.22%
    Accounts Payable 37.11K 37.11K $0.00 +0.00%
    Operating Lease Liabilities 1.09K 1.09K $-7.00 -0.64%
    Interest Expense 435.00 762.00 $-327.00 -42.91%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: LIGAND PHARMACEUTICALS INC
    • Ticker Symbol: LGND

Search

News categories